Form D · Biotechnology
Oncodea Corp
Saint Paul, MN · CIK 0001925609
Offering snapshot reported Apr 29, 2022 · SEC filing
- Reported sold
- $276K Offering amount: $850K
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Apr 19, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 29, 2022 | Initial | $275,818 | No comparison | 4 | SEC filing |
Offering details
- Securities
- Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-443937
No Executive Officer, Director or Promoter has, nor will ever, receive any form of monetary commissions as a result of this offering.
Source: Form D, filed Apr 29, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Ali Khammanivong | Director |
| Dan Que Pham | Director, Executive |
| Yung Ping Yeh | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1000 Westgate Drive #1002
Saint Paul, MN, 55114
Saint Paul, MN, 55114